Ottino Paulo, Taheri Faramarz, Bazan Haydee E P
Department of Ophthalmology and Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Exp Eye Res. 2002 Mar;74(3):393-402. doi: 10.1006/exer.2001.1135.
Previous studies in the laboratory have shown that platelet-activating factor (PAF), a potent inflammatory mediator that accumulates rapidly in the cornea after an injury, stimulates the expression of urokinase (uPA) and matrix metalloproteinase-1 (MMP-1) and -9 (MMP-9). Tissue inhibitors of MMPs (TIMPs) and plasminogen activator inhibitor (PAI-1) are produced in conjunction with these enzymes and are important regulators of their activity. Here, the authors investigated how PAF affects the expression of PAI-1, TIMP-1 and -2 relative to that of uPA, MMP-1, and -9 in rabbit corneal epithelial cells. Rabbit corneas were incubated in MEM medium containing 100 nM cPAF. To block the effects of PAF in some studies, corneas were preincubated for 1 hr in the presence of the PAF antagonist BN50730 (10 microM). At several time intervals, mRNA was extracted from epithelial cells and the levels of gene expression for the enzymes and their inhibitors were determined by real-time PCR. All quantitations were normalized to the 18s rRNA values (endogenous control) and changes in gene expression were reported as fold increase relative to untreated controls. PAF produced a 20-fold increase in the gene expression of PAI-1 at 8 hr, while similar fold increases in uPA mRNA expression occurred at 2 hr. PAF treatment also stimulated the expression of TIMP-1 and -2 genes, with a six-fold increase in TIMP-1 expression occurring at 36 hr and a four-fold increase in TIMP-2 expression at 24 hr. Maximal induction of MMP-1 and -9 mRNA, on the other hand, occurred at 4 and 8 hr, respectively. Induction of MMP-1 gene expression was similar to that of its inhibitors TIMP-1 and -2, while MMP-9 mRNA induction exceeded that of these inhibitors by 100-fold. The PAF-induced expression of PAI-1, TIMP-1 and -2 mRNAs was abolished by pre-treatment with BN50730. These data indicate that PAF activates the gene expression of TIMP-1, -2, and PAI-1 in corneal epithelium by a receptor-mediated mechanism. Furthermore, PAF induced overexpression of MMP-9 mRNA relative to that of TIMP-1 and -2, suggesting an imbalance between the expression of this proteolytic enzyme and its inhibitors, which may contribute to changes in the wound-healing process and ultimately lead to corneal ulcer development.
此前实验室研究表明,血小板活化因子(PAF)是一种强效炎症介质,在损伤后可迅速在角膜中蓄积,能刺激尿激酶(uPA)、基质金属蛋白酶-1(MMP-1)和基质金属蛋白酶-9(MMP-9)的表达。基质金属蛋白酶组织抑制剂(TIMPs)和纤溶酶原激活物抑制剂(PAI-1)与这些酶共同产生,是其活性的重要调节因子。在此,作者研究了PAF如何影响兔角膜上皮细胞中PAI-1、TIMP-1和TIMP-2相对于uPA、MMP-1和MMP-9的表达。将兔角膜在含有100 nM cPAF的MEM培养基中孵育。在一些研究中,为阻断PAF的作用,角膜在PAF拮抗剂BN50730(10 microM)存在下预孵育1小时。在几个时间间隔,从上皮细胞中提取mRNA,并通过实时PCR测定酶及其抑制剂的基因表达水平。所有定量均以18s rRNA值(内参)进行标准化,基因表达变化以相对于未处理对照的增加倍数表示。PAF在8小时时使PAI-1的基因表达增加20倍,而uPA mRNA表达在2小时时出现类似倍数的增加。PAF处理还刺激了TIMP-1和TIMP-2基因的表达,TIMP-1表达在36小时时增加6倍,TIMP-2表达在24小时时增加4倍。另一方面,MMP-1和MMP-9 mRNA的最大诱导分别出现在4小时和8小时。MMP-1基因表达的诱导与其抑制剂TIMP-1和TIMP-2相似,而MMP-9 mRNA的诱导比这些抑制剂高出100倍。用BN50730预处理可消除PAF诱导的PAI-1、TIMP-1和TIMP-2 mRNA的表达。这些数据表明,PAF通过受体介导的机制激活角膜上皮中TIMP-1、TIMP-2和PAI-1的基因表达。此外,相对于TIMP-1和TIMP-2,PAF诱导MMP-9 mRNA的过表达,提示这种蛋白水解酶与其抑制剂的表达失衡,这可能导致伤口愈合过程发生变化,并最终导致角膜溃疡形成。